David Weill
Direttore/Membro del Consiglio presso TRANSMEDICS GROUP, INC.
Patrimonio netto: 998 975 $ in data 30/04/2024
Posizioni attive di David Weill
Società | Posizione | Inizio | Fine |
---|---|---|---|
TRANSMEDICS GROUP, INC. | Direttore/Membro del Consiglio | 01/01/2019 | - |
Independent Dir/Board Member | 01/01/2019 | - | |
Weill Consulting Group | Corporate Officer/Principal | 01/01/2016 | - |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di David Weill
Precedenti posizioni note di David Weill
Società | Posizione | Inizio | Fine |
---|---|---|---|
Stanford University Medical Center | Corporate Officer/Principal | 01/01/2005 | 01/01/2016 |
Stanford Center For Advanced Lung Diseases | Direttore/Membro del Consiglio | - | - |
Formazione di David Weill
Tulane University (Louisiana) | Undergraduate Degree |
Tulane University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
TRANSMEDICS GROUP, INC. | Health Technology |
Aziende private | 4 |
---|---|
Weill Consulting Group | |
Stanford Center For Advanced Lung Diseases | |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Health Technology |
Stanford University Medical Center |
- Borsa valori
- Insiders
- David Weill
- Esperienza